338 related articles for article (PubMed ID: 34065409)
1. Vascular Endothelial Growth Factor Biology and Its Potential as a Therapeutic Target in Rheumatic Diseases.
Le THV; Kwon SM
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34065409
[TBL] [Abstract][Full Text] [Related]
2. [VEGF and its receptors as therapeutic target in cancer therapy].
Gisterek I; Kornafel J
Przegl Lek; 2006; 63(3):155-7. PubMed ID: 16967703
[TBL] [Abstract][Full Text] [Related]
3. Vascular endothelial growth factors and angiogenesis in eye disease.
Witmer AN; Vrensen GF; Van Noorden CJ; Schlingemann RO
Prog Retin Eye Res; 2003 Jan; 22(1):1-29. PubMed ID: 12597922
[TBL] [Abstract][Full Text] [Related]
4. Placental growth factor neutralising antibodies give limited anti-angiogenic effects in an in vitro organotypic angiogenesis model.
Brave SR; Eberlein C; Shibuya M; Wedge SR; Barry ST
Angiogenesis; 2010 Dec; 13(4):337-47. PubMed ID: 20953695
[TBL] [Abstract][Full Text] [Related]
5. An Overview of VEGF-Mediated Signal Transduction.
Evans I
Methods Mol Biol; 2015; 1332():91-120. PubMed ID: 26285748
[TBL] [Abstract][Full Text] [Related]
6. Different vascular endothelial growth factor (VEGF), VEGF-receptor 1 and -2 mRNA expression profiles between clear cell and papillary renal cell carcinoma.
Ljungberg BJ; Jacobsen J; Rudolfsson SH; Lindh G; Grankvist K; Rasmuson T
BJU Int; 2006 Sep; 98(3):661-7. PubMed ID: 16925769
[TBL] [Abstract][Full Text] [Related]
7. Vascular endothelial cell growth factor (VEGF), an emerging target for cancer chemotherapy.
Shinkaruk S; Bayle M; Laïn G; Déléris G
Curr Med Chem Anticancer Agents; 2003 Mar; 3(2):95-117. PubMed ID: 12678905
[TBL] [Abstract][Full Text] [Related]
8. Role of the vascular endothelial growth factor isoforms in retinal angiogenesis and DiGeorge syndrome.
Stalmans I
Verh K Acad Geneeskd Belg; 2005; 67(4):229-76. PubMed ID: 16334858
[TBL] [Abstract][Full Text] [Related]
9. The biology of VEGF and its receptors.
Ferrara N; Gerber HP; LeCouter J
Nat Med; 2003 Jun; 9(6):669-76. PubMed ID: 12778165
[TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial growth factors and receptors: anti-angiogenic therapy in the treatment of cancer.
Tugues S; Koch S; Gualandi L; Li X; Claesson-Welsh L
Mol Aspects Med; 2011 Apr; 32(2):88-111. PubMed ID: 21565214
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of vascular endothelial growth factor (VEGF), endocrine gland derived-VEGF, and VEGF receptors in human placentas from normal and preeclamptic pregnancies.
Chung JY; Song Y; Wang Y; Magness RR; Zheng J
J Clin Endocrinol Metab; 2004 May; 89(5):2484-90. PubMed ID: 15126581
[TBL] [Abstract][Full Text] [Related]
12. VEGFs and receptors involved in angiogenesis versus lymphangiogenesis.
Lohela M; Bry M; Tammela T; Alitalo K
Curr Opin Cell Biol; 2009 Apr; 21(2):154-65. PubMed ID: 19230644
[TBL] [Abstract][Full Text] [Related]
13. The power of VEGF (vascular endothelial growth factor) family molecules.
Thomas JL; Eichmann A
Cell Mol Life Sci; 2013 May; 70(10):1673-4. PubMed ID: 23475064
[TBL] [Abstract][Full Text] [Related]
14. Vascular endothelial growth factor (VEGF), VEGF receptors expression and microvascular density in benign and malignant thyroid diseases.
Jebreel A; England J; Bedford K; Murphy J; Karsai L; Atkin S
Int J Exp Pathol; 2007 Aug; 88(4):271-7. PubMed ID: 17696908
[TBL] [Abstract][Full Text] [Related]
15. VEGF (Vascular Endothelial Growth Factor) and Fibrotic Lung Disease.
Barratt SL; Flower VA; Pauling JD; Millar AB
Int J Mol Sci; 2018 Apr; 19(5):. PubMed ID: 29695053
[TBL] [Abstract][Full Text] [Related]
16. The direct effects of anti-vascular endothelial growth factor therapy on tumor cells.
Moser C; Lang SA; Stoeltzing O
Clin Colorectal Cancer; 2007 Jul; 6(8):564-71. PubMed ID: 17681102
[TBL] [Abstract][Full Text] [Related]
17. Tumor angiogenesis and anti-angiogenic therapies.
Shahneh FZ; Baradaran B; Zamani F; Aghebati-Maleki L
Hum Antibodies; 2013; 22(1-2):15-9. PubMed ID: 24284305
[TBL] [Abstract][Full Text] [Related]
18. The vascular endothelial growth factors and receptors family: Up to now the only target for anti-angiogenesis therapy.
Tarallo V; De Falco S
Int J Biochem Cell Biol; 2015 Jul; 64():185-9. PubMed ID: 25936669
[TBL] [Abstract][Full Text] [Related]
19. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
[TBL] [Abstract][Full Text] [Related]
20. The role of vascular endothelial growth factors and their receptors in malignant melanomas.
Brychtova S; Bezdekova M; Brychta T; Tichy M
Neoplasma; 2008; 55(4):273-9. PubMed ID: 18505336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
